Nordson (NDSN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Jan, 2026Executive summary
The annual meeting will be held virtually on March 2, 2026, with shareholders able to vote online, by phone, mail, or during the meeting.
Key proposals include electing three directors, ratifying the appointment of Ernst & Young LLP as auditor, and an advisory vote on executive compensation.
Record sales of $2.8 billion and EBITDA of $900 million were achieved in 2025, with a 4% sales increase and continued dividend growth for the 62nd consecutive year.
The company emphasizes long-term shareholder value, strong governance, and a pay-for-performance compensation philosophy.
Voting matters and shareholder proposals
Shareholders will vote on electing three directors, ratifying Ernst & Young LLP as auditor for FY2026, and approving executive compensation on an advisory basis.
Board recommends voting FOR all proposals.
No other matters are expected, but proxies may vote on any new business that arises.
Board of directors and corporate governance
Board consists of ten directors, 90% of whom are independent, with an average age of 63 and average tenure of 7 years.
Board refreshment has added six new directors since 2019, enhancing diversity and expertise.
Independent Chair leads the board, and all committees are composed solely of independent directors.
Directors are subject to mandatory retirement at 72 and must meet share ownership guidelines.
Board and committees held 18 meetings in 2025, with 100% attendance by all directors.
Latest events from Nordson
- Record sales and earnings, with raised guidance and strong growth in ATS and Asia Pacific.NDSN
Q1 202619 Feb 2026 - Strong growth, innovation, and cash flow support 6-8% annual revenue growth through 2029.NDSN
Investor presentation19 Feb 2026 - Q3 sales up 2% to $662M; Atrion acquisition expands medical segment; guidance raised.NDSN
Q3 202423 Jan 2026 - 2025–2029 targets 6%-8% revenue and 10%-12% EPS growth, driven by strategy and portfolio evolution.NDSN
Investor Day 202420 Jan 2026 - Annual meeting to elect directors, ratify auditor, and approve executive pay, all board-recommended.NDSN
Proxy Filing16 Jan 2026 - Record sales and EBITDA in 2024; 2025 outlook targets growth, led by Atrion amid macro uncertainty.NDSN
Q4 202411 Jan 2026 - Sales fell 2.8% but backlog surged 15%, signaling growth potential for 2025.NDSN
Q1 20258 Jan 2026 - Record sales, strong margins, and robust cash flow set up for solid growth in 2026.NDSN
Q4 202512 Dec 2025 - Record financials, strong governance, and key votes headline the 2025 proxy.NDSN
Proxy Filing1 Dec 2025